Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based Scarguard Labs, which is engaged in the treatment of scars and other dermatological problems through the use of multi-technology drugs enhanced by a proprietary contact delivery system, has appointed Richard Pino as its new CFO.
Subscribe to our email newsletter
Mr Pino will be responsible for the company’s finance, accounting and treasury functions and will report to Joel Studin, the company’s CEO.
Prior to his appointment, Mr Pino served as CFO/COO for EcoSys Management. Previously, he was the CFO for The Relegence Corporation, which became a wholly owned subsidiary of AOL, a TimeWarner Company during Mr Pino’s tenure.
Dr Studin said: “We couldn’t be happier that Richard agreed to join our company. His experience covers all aspects of the finance, treasury and accounting roles, and includes strategic planning, mergers and acquisitions, all roles that he will fulfill while at Scarguard. He will be a key part of Scarguard’s growth as a company.”